Structural and mechanistic mapping of a unique fumarate reductase by Taylor, Paul et al.
letters
1108 nature structural biology • volume 6 number 12 • december 1999 
Structural and mechanistic
mapping of a unique
fumarate reductase
Paul Taylor1, Sara L. Pealing1,2, Graeme A. Reid1,
Stephen K. Chapman2 and Malcolm D. Walkinshaw1
1Institute of Cell and Molecular Biology, University of Edinburgh, Mayfield
Road, Edinburgh EH9 3JR, UK. 2Department of Chemistry, University of
Edinburgh, West Mains Road, Edinburgh EH9 3JJ, UK.
The 1.8 Å resolution crystal structure of the tetraheme flavo-
cytochrome c3, Fcc3, provides the first mechanistic insight
into respiratory fumarate reductases or succinate dehydro-
genases. The multi-redox center, three-domain protein
shows a 40 Å long ‘molecular wire’ allowing rapid conduc-
tion of electrons through a new type of cytochrome domain
onto the active site flavin, driving the reduction of fumarate
to succinate. In this structure a malate-like molecule is
trapped in the enzyme active site. The interactions between
this molecule and the enzyme suggest a clear mechanism for
fumarate reduction in which the substrate is polarized and
twisted, facilitating hydride transfer from the reduced
flavin and subsequent proton transfer. The enzyme active
site in the oxidized form is completely buried at the inter-
face between the flavin-binding and the clamp domains.
Movement of the cytochrome and clamp domains is postu-
lated to allow release of the product.
The growth of Shewanella frigidimarina NCIMB400 under
anaerobic conditions induces the synthesis of several novel
cytochromes, the most abundant of which is a tetraheme Fcc3 (Mr
63.8 kDa). The gene encoding Fcc3 has been cloned and sequenced
(Swissprot entry FRDA_SHEPU) and the protein product has
been shown to be a unique respiratory fumarate reductase1,2. It
differs from other bacterial fumarate reductases, which are multi-
subunit and anchored to the inner face of the cytoplasmic mem-
brane3. In contrast Fcc3 is a soluble, single chain enzyme found in
the periplasm4. The N-terminal cytochrome domain contains four
covalently bound heme groups and shows no significant sequence
Fig. 1 2Fo - Fc difference electron density. The stereo picture shows a
portion of the final σ-weighted (2Fo-Fc) map about the flavin group and
the modified substrate (BOBSCRIPT29).
Fig. 2 Structural features of Fcc3. a, Domain
structure of Fcc3. The three domains of Fcc3
were drawn using the program MOLSCRIPT30
and are color coded. Heme domain (blue),
residues 1–107; flavin-binding domain (red),
residues 108–364 and 503–568; clamp domain
(green), residues 365–502. The sodium ion (indi-
go) is buried in the flavin domain. b, Cα trace of
Fcc3. Stereo view with every 20th. residue
labeled. c, The spatial disposition of the five
redox centers of the enzyme. The edge-to-edge
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similarity to any cytochrome of known three-dimensional struc-
ture. The flavin adenine dinucleotide (FAD)  binding domain is
related by sequence to the flavoprotein subunits of the membrane-
bound fumarate reductases and succinate dehydrogenases1. The
recent X-ray structure of the E. coli fumarate reductase respiratory
complex5 provides insight into the general architecture of an iron-
sulfur based reductase, but at 3.3 Å shows little detail at the active
site. In contrast the high resolution structure of Fcc3, a
cytochrome-linked reductase, provides the first insight into the
detailed mechanism of fumarate reduction. These new fumarate
reductase structures together with the X-ray structures of
cytochrome c oxidase6 and the cytochrome bc1 complex7, greatly
enhance our molecular understanding of respiratory mechanisms.
Overview of the structure
The initial electron density map with phases from the anomalous
iron signal was of exceptionally high quality and most of the chain
could be unambiguously traced from the initial 2.4 Å map. The
four heme groups and the FAD group were easily identified. Data
to 1.8 Å were used to refine the structure to a final R-factor of
19.2% (Table 1) and the quality of the final electron density map is
shown in Fig. 1.
The single polypeptide chain of 571 amino acids folds into three
distinct domains (Fig. 2a,b). The N-terminal, 100 amino acid
cytochrome domain containing four heme groups is tethered to
the flavin domain by a charged bent helix linker (residues
100–110). The flavin domain (residues 111–364 and 503–571 col-
ored red in Fig. 3) holds the noncovalently bound FAD group. The
overall fold of the FAD binding domain has a structural and topo-
logical similarity to known FAD binding proteins, although the
sequence similarity is poor: there is 18% sequence identity with
lipoamide dehydrogenase8 and 19% identity with glutathione
reductase9. An even weaker sequence similarity is found with
NADH peroxidase10 despite the fact that superposition of the
structures indicates that ~90 amino acids show a reasonable struc-
tural correspondence. The most closely related proteins of known
structure are L-aspartate oxidase11 and E. coli fumarate reductase5,
which have sequence identities of 38% and 45%, respectively, over
the length of the 121 residues corresponding to the Rossmann
fold. A fit of the flavin domain of Fcc3 onto the flavin binding
domain of L-aspartate oxidase gives a residual mean standard
deviation (r.m.s.d.) of 1.7 Å for 103 corresponding Cα atoms.
Buried within the flavin domain is an octahedrally coordinated
sodium ion (Fig. 2a,b) that is close to the active site and may well
play a structural or regulatory role12.
The clamp domain of Fcc3 (residues 365–502, shown in yel-
low in Fig. 2a) is likely to be involved in controlling access of
substrate to the active site. It consists of seven short helical
a b
c
Fig. 3 The active site of Fcc3. a, Stereo MOLSCRIPT30 representation of the environment of the modified substrate. Hydrogen bonds are shown as red
dashed lines. Other short contacts are shown as green dashed lines. Distances are also tabulated showing hydrogen bonds and short nonbonded contacts
(<3.1 Å) involving the modified substrate. b, Connolly surfaces of the available active site volume (green) and substrate-occupied volume (red). The
Connolly surface of the available volume in the substrate binding site (transparent green surface) is almost completely filled by the substrate intermediate
molecule. The Connolly surface of the substrate intermediate molecule shown as a wire representation colored red. c, An overlay of a modeled planar
fumarate (magenta) and the modified substrate. Short contacts between the modeled fumarate molecule and the two clamping methionine residues are
shown. The resulting twist in the conformation of the carboxyl group is important in the enzyme mechanism.
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stretches wrapped round a four-stranded
antiparallel sheet. There is no obviously
similar three-dimensional structure and
searches using the programs VAST13,
TOPS14 and DALI15 provide only weakly
similar folds.
Relationship of the five redox
cofactors
The redox properties of Fcc3 have recently
been investigated using protein film
voltammetry, allowing the reduction
potentials of all five redox cofactors to be
determined16. The ‘dog leg’ arrangement
of the four heme groups is unique in the
family of cytochromes c3. The edge-to-
edge distances between the heme groups
vary from 3.9 Å to 8.0 Å (Fig. 2c) that are
ideal for efficient inter-heme electron
transfer. Heme 4 is 7.4 Å (edge-to-edge)
from the FAD. This compares well to the heme–flavin distance
of 9.7 Å seen in flavocytochrome b2 (ref. 17), one of the few
other structurally characterized flavocytochromes. The overall
positioning of the redox centers in Fcc3 represents a 40 Å long
‘molecular wire’ running through the protein which enhances
our understanding of previously published kinetic and ther-
modynamic data16,18.
The reduction potential for the FAD is -152 mV and the four
hemes have values of -238 mV, -196 mV, -146 mV, -102 mV16.
In common with other c-type cytochromes, the hemes are
covalently linked to two cysteines in the CxxCH motif. In all
cases histidines provide the fifth and sixth ligands for the iron.
The structure confirms that, as predicted by electron paramag-
netic resonance (EPR) spectroscopy19, two hemes have their
Fig. 4 Reaction mechanisms at the Fcc3 active
site. a, Schematic representation of the mecha-
nism of fumarate reduction by Fcc3. Catalysis is
initiated by the binding of fumarate at the
active site. The C1 carboxylate group of
fumarate (to the left in this representation) is
twisted out of plane by the closure of the clamp
domain and the resulting steric constraints
imposed by the side chains of Met 236 and Met
375 (Fig. 3d) and by hydrogen bonding to His
365. The substrate C4 carboxylate is bound in a
very positively charged environment involving
interactions with His 504, Arg 544 and Arg 402.
The combination of these effects results in
polarization of the C2–C3 bond with the build
up of positive charge at C2, facilitating hydride
transfer from N5 of the reduced flavin to the si-
face of the substrate. Arg 402 which is only 2.99
Å from C3, is ideally positioned for proton
transfer, resulting in the formation of the prod-
uct, succinate. b, Proposed mechanism for the
formation of the hydrated intermediate at the
active site of the oxidized enzyme. In the oxi-
dized flavocytochrome c3, as is the case in the
crystal, there is no hydride available to attack
the substrate C2 atom. Instead, water acts as a
nucleophile attacking the re-face. The resulting
intermediate, which is shown in the electron
density to have R-stereochemistry at C2, is
trapped at the active site in the crystal.
c, Conservation of active site residues in
fumarate reductases and succinate dehydroge-
nases. Segments of the sequence of Fcc3 are
aligned with the corresponding regions of the
flavoprotein subunits of the fumarate reduc-
tases from E. coli (frda_ecoli) and Wolinella suc-
cinogenes (frda_wolsu) and the succinate
dehydrogenases from E.coli (dhsa_ecoli) and
Saccharomyces cerevisiae (dhsa_yeast) to high-
light the conservation around active site
residues. The following residues are highlight-
ed in red: His 365 and Thr 377 (top left), Arg 402
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imidazole ligating groups parallel and two perpendicular to
each other, and these are possibly involved in fine tuning the
reduction potentials of the hemes. There is no significant
sequence conservation between this tetraheme domain and any
other heme-containing proteins the X-ray structures of which
are known. There is, however, an interesting similarity in the
arrangement of three of the heme groups in hydroxylamine
oxidoreductase20.
Mechanism of fumarate reduction
The crystallization medium contained a 10 mM solution of
fumarate, well above the KM of 25 µM19, suggesting that the
active site of Fcc3 should be fully occupied. However, the differ-
ence electron density map clearly shows the presence of a
hydrated malate-like molecule in the enzyme active site of Fcc3. It
is unlikely that this molecule is oxaloacetate because the protein is
crystallized from the fully active enzyme that was purified in the
complete absence of oxaloacetate. The malate-like molecule is held
tightly by 11 hydrogen bonds (Fig. 3a) and sits in a close-fitting
binding site that is completely inaccessible to solvent (Fig. 3b). The
tight steric constraints of the active site require that the C1 car-
boxyl group twists out of the plane. A model of an idealized planar
fumarate was fitted onto the observed malate-like molecule by
superposing the C4 carboxyl groups (Fig. 3c). The modeled
fumarate shows short contacts between the C1 carboxyl group and
the side chains of Met 236 and Met 375. This interaction provides
the drive to twist the substrate out of the planar conformation,
which has the additional effect of weakening the conjugation
throughout the molecule. The exceptionally polar hydrogen
bonding environment of the C4 carboxyl group, with contribu-
tions from two arginines and a histidine, acts to polarize the
fumarate. The combined steric and electronic effects then rein-
force each other to generate considerable positive charge at C2
(Fig. 4), making it amenable to the subsequent nucleophilic attack.
In the biologically relevant mechanism (Fig. 4a), a hydride on N5
of the flavin ring would be positioned less than 3.2 Å from C2,
poised to attack the si-face of the C2 center. Under the oxidizing
conditions used for crystal growth, hydride attack is not possible
and instead there is attack by H2O on the re-face to provide the
observed product, which has R-stereochemistry at C2 (Fig. 4b).
In the final rounds of refinement, bond distance and bond angle
restraints (consistent with malate) for the substrate were removed
and the model converged on a geometry consistent with the prod-
uct shown in Fig. 4b. In particular, the C4-C3-C2 angle refined to
120° while that of C1-C2-C3 refined to 110°. The interaction
between Arg 402 NH2 and substrate C3 which are separated by
2.99 Å is then understood in terms of the interaction between the
δ+ charge of the arginine side chain with the delocalized π-elec-
trons of the C3–C4 partial double bond. The geometry of the lig-
and and the close NH–C3 contact show that the substrate has been
hydroxylated but not yet protonated (by the arginine) and we have
trapped a stable intermediate in the active site of the crystal.
Furthermore, the intermediate defined in the Fcc3 structure speci-
fies the time course of the reaction, showing that hydride transfer
to C2 occurs before proton transfer to C3.
The enclosed nature of the active site (Fig. 3b) suggests that a
conformational change is required to allow succinate product to
diffuse out and fumarate substrate to enter. An insight to this
mechanism comes from the X-ray structure of the two domain
L-aspartate oxidase11 which has been solved in an open (FAD-
free) conformation. The clamp domain of L-aspartate oxidase
shows 30% sequence identity to the clamp domain of Fcc3. The
displacement of the cytochrome and clamp domains of Fcc3 with
respect to the flavin domain would allow free access to the sub-
strate binding pocket and could be achieved by conformational
changes in the interdomain linking peptides 364–366 and
500–503, and the long tether (residues 100–108).
One important consequence of this X-ray crystal structure is
its relevance to other members of the fumarate reductase/succi-
nate dehydrogenase family, which are key components of respi-
ratory pathways. There are four key aspects to the Fcc3
mechanism: (i) delivery of electrons to the flavin, (ii) the highly
polarized recognition site (iii) the induced twist in the fumarate
substrate and (iv) the domain movement to allow release of the
Table 1 Data collection, phasing and refinement statistics
MAD data reduction statistics (24.0–2.4 Å)
Data set Wavelength (Å) Unique reflections Completeness (%) <I>/<σ(I)> Rmerge(%)1
Anom. Peak 1.736 25,101 98.7 20.9 7.7
Infl. Point 1.738 20,031 79.1 22.1 8.8
Remote 1.488 22,628 89.8 18.6 6.2
Phasing (24.0–2.4 Å)
Overall Figure of merit SOLVE: 0.47 DM: 0.66
Refinement (24.0–1.8 Å)
Unique reflections Completeness (%) <I>/<σ(I)> Rmerge(%)1
54,988 92.5 13.2 8.3
Rcryst (%)2 19.2
Rfree (%)2 26.7
R.m.s.d. from restraint values
Bond length (Å) 0.007





1Rmerge = Σ|<I> -I| / Σ<I>; over all reflections.
2Rcryst = Σ|Fo - Fc| / Fo; Rfree calculated with 10% data withheld from refinement.
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substrate. The extensive sequence similarity between the flavin-
binding region of Fcc3 and other fumarate reductases/succinate
dehydrogenases is consistent with the idea that a common cat-
alytic mechanism operates for all members of this important
enzyme group. The key residues involved in substrate binding
and catalysis (Arg 402, Arg 544, His 504, His 365, Thr 377) are
conserved in all members of this enzyme family (Fig. 4c). The
membrane-bound fumarate reductases and succinate dehydro-
genases, however, use iron-sulfur clusters as electron mediating
groups3. Thus, the X-ray structure of Fcc3 provides a major
insight into a general mechanism for fumarate reduction and
identifies a unique pathway for electron flow to the flavin, medi-
ated by the four heme groups.
Methods
Structure determination. Protein purification and preliminary
crystallographic work has been published21. Native data were col-
lected on a MarResearch image plate at station 7.2 at the SRS in
Daresbury, with MAD data collected using a similar instrument at the
EMBL outstation DESY in Hamburg. For all data sets the processing
was carried out using the HKL package22. All four iron atoms were
located using anomalous and difference Patterson maps calculated
with the CCP4 suite23. Subsequently the program SOLVE24 was used
and the same iron positions were determined. When phase estimates
from SOLVE were solvent-flattened using the program DM25, the
heme groups and attached amino acids were visible in the electron
density as was the FAD. In a map calculated using 2.4 Å data it was
possible to trace ~80% of the polypeptide chain using the graphics
program WITNOTP26. This model was then refined using the maxi-
mum likelihood torsional dynamics algorithm from CNS27.
Refinement was completed using the 1.8 Å native data set with the
program SHELXL-97 (ref. 28), using the same test set of reflections as
had been used with CNS. Restraints for the heme groups were calcu-
lated from the CNS parameter file and for the FAD from two small
molecule crystal structures (Cambridge Crystallographic Database
codes HMADPH and VEFHUJ10). The model consists of residues 1–568,
four hemes, the FAD, a modified substrate molecule, one sodium
ion, a glycerol molecule and 584 water molecules. One cis peptide
bond, between Ala 175 and Trp 176, was clearly identified. The
three C-terminal residues of the (569–571) were not located.
Coordinates. The atomic coordinates have been deposited in the
Protein Data Bank (accession code 1qjd).
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